/
/
/

Aarti Drugs Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015
₹703 Cr₹720 Cr₹602 Cr₹653 Cr₹591 Cr₹677 Cr₹557 Cr₹598 Cr₹555 Cr₹620 Cr₹606 Cr₹642 Cr₹661 Cr₹742 Cr₹664 Cr₹688 Cr₹622 Cr₹694 Cr₹635 Cr₹580 Cr₹580 Cr₹502 Cr₹530 Cr₹578 Cr₹545 Cr₹450 Cr₹474 Cr₹478 Cr₹405 Cr₹459 Cr₹380 Cr₹347 Cr₹374 Cr₹331 Cr₹335 Cr₹319 Cr₹277 Cr₹320 Cr₹310 Cr₹342 Cr₹315 Cr₹340 Cr₹269 Cr₹273 Cr₹284 Cr
₹81 L₹76 L₹1 Cr₹9 L₹31 L₹2 Cr₹12 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹68 L₹60 L₹87 L₹1 Cr₹6 L₹26 L₹3 Cr₹7 Cr₹8 L₹2 Cr₹97 L₹2 Cr₹29 L₹1 Cr₹98 L₹25 L₹19 L₹6 L₹1 Cr₹17 L₹10 L₹92 L₹77 L₹13 L₹8 L₹7 L₹2 Cr₹87 L₹58 L₹32 L₹0₹0₹0₹0
₹704 Cr₹721 Cr₹603 Cr₹653 Cr₹591 Cr₹679 Cr₹569 Cr₹600 Cr₹556 Cr₹621 Cr₹608 Cr₹642 Cr₹662 Cr₹743 Cr₹665 Cr₹688 Cr₹622 Cr₹697 Cr₹641 Cr₹580 Cr₹582 Cr₹503 Cr₹532 Cr₹578 Cr₹546 Cr₹451 Cr₹474 Cr₹478 Cr₹405 Cr₹460 Cr₹380 Cr₹348 Cr₹375 Cr₹331 Cr₹336 Cr₹319 Cr₹277 Cr₹322 Cr₹311 Cr₹343 Cr₹316 Cr₹340 Cr₹269 Cr₹273 Cr₹284 Cr
₹623 Cr₹643 Cr₹565 Cr₹585 Cr₹531 Cr₹598 Cr₹509 Cr₹545 Cr₹504 Cr₹548 Cr₹548 Cr₹578 Cr₹590 Cr₹661 Cr₹606 Cr₹626 Cr₹567 Cr₹621 Cr₹557 Cr₹518 Cr₹513 Cr₹433 Cr₹437 Cr₹474 Cr₹423 Cr₹391 Cr₹418 Cr₹421 Cr₹363 Cr₹414 Cr₹339 Cr₹311 Cr₹332 Cr₹284 Cr₹291 Cr₹277 Cr₹252 Cr₹283 Cr₹278 Cr₹301 Cr₹277 Cr₹304 Cr₹235 Cr₹239 Cr₹248 Cr
₹99 Cr₹97 Cr₹56 Cr₹84 Cr₹74 Cr₹95 Cr₹74 Cr₹69 Cr₹66 Cr₹87 Cr₹72 Cr₹77 Cr₹85 Cr₹94 Cr₹72 Cr₹74 Cr₹67 Cr₹89 Cr₹97 Cr₹74 Cr₹81 Cr₹82 Cr₹108 Cr₹117 Cr₹135 Cr₹72 Cr₹68 Cr₹68 Cr₹55 Cr₹57 Cr₹52 Cr₹47 Cr₹54 Cr₹57 Cr₹54 Cr₹53 Cr₹35 Cr₹49 Cr₹43 Cr₹51 Cr₹48 Cr₹46 Cr₹43 Cr₹43 Cr₹44 Cr
₹9 Cr₹8 Cr₹9 Cr₹8 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹8 Cr₹8 Cr₹9 Cr₹9 Cr₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹7 Cr₹7 Cr₹7 Cr₹8 Cr₹9 Cr₹9 Cr₹10 Cr₹10 Cr₹10 Cr₹9 Cr₹9 Cr₹9 Cr₹8 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹10 Cr₹12 Cr₹11 Cr₹11 Cr₹10 Cr
₹69 Cr₹70 Cr₹29 Cr₹60 Cr₹51 Cr₹71 Cr₹51 Cr₹46 Cr₹44 Cr₹64 Cr₹52 Cr₹56 Cr₹64 Cr₹73 Cr₹50 Cr₹53 Cr₹48 Cr₹71 Cr₹79 Cr₹56 Cr₹65 Cr₹65 Cr₹90 Cr₹97 Cr₹116 Cr₹61 Cr₹43 Cr₹48 Cr₹34 Cr₹40 Cr₹31 Cr₹27 Cr₹34 Cr₹38 Cr₹35 Cr₹35 Cr₹17 Cr₹31 Cr₹24 Cr₹33 Cr₹28 Cr₹25 Cr₹23 Cr₹23 Cr₹25 Cr
₹50 Cr₹55 Cr₹41 Cr₹45 Cr₹54 Cr₹63 Cr₹37 Cr₹35 Cr₹33 Cr₹47 Cr₹37 Cr₹40 Cr₹48 Cr₹56 Cr₹37 Cr₹39 Cr₹35 Cr₹55 Cr₹58 Cr₹43 Cr₹49 Cr₹52 Cr₹68 Cr₹75 Cr₹85 Cr₹59 Cr₹28 Cr₹32 Cr₹22 Cr₹27 Cr₹21 Cr₹18 Cr₹23 Cr₹24 Cr₹23 Cr₹24 Cr₹11 Cr₹22 Cr₹18 Cr₹22 Cr₹20 Cr₹19 Cr₹17 Cr₹16 Cr₹17 Cr

Share Price Live Stats

Open (₹)420.85
Volume (₹)3.80 L
High (₹)440.60
Upper Circuit501.35
Low (₹)419.50
Lower Circuit334.25
Prev Close417.80
52W High (₹)534.55
Price425.85
52W Low (₹)318.95

Share Market Cap & Key Ratios Overview

M.Cap (₹)3808.70 Cr
Div. Yield (%)0.48
PE Ratio19.92
Debt to Equity0.45
Price to Book2.27
Book Value149.99
EPS (TTM)20.95
Face Value10.00
ROE (%)12.68

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
AARTIDRUGSNSE
LTP
1W Low
1W High
Market cap (₹)
1916-4 (-0.21%)
1905
1984.80
4,63,791Cr
9250+11 (0.12%)
9087
9467
2,45,081Cr
4905.5-144.5 (-2.86%)
4886.50
5066
1,90,351Cr
1143-48 (-4.03%)
1130.50
1187
1,14,833Cr
1394.7-28.8 (-2.02%)
1389.40
1426.10
1,14,163Cr
1868.5-70 (-3.61%)
1811.70
1949
1,00,660Cr
2132-39.5 (-1.82%)
2132
2192
98,431Cr
2368.8-14.1 (-0.59%)
2341.20
2419.20
98,305Cr
1155-23 (-1.95%)
1154.40
1179.90
96,906Cr
1637.3-8 (-0.49%)
1626.60
1717
95,300Cr
425.85+7.3 (1.74%)
409.95
440.60
3,809Cr

Key Highlights of Aarti Drugs Ltd’s P&L

In 2025-03-31, Aarti Drugs Ltd reported total revenue of ₹2403.39Cr, compared with ₹2532.61Cr in 2024-03-31, reflecting Aarti Drugs Ltd turnover.

Depreciation was ₹55.78Cr and finance costs were ₹39.04Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹211.77Cr in 2025-03-31 as compared to ₹235.53Cr in 2024-03-31.

Net Profit (PAT) was ₹168.16Cr in 2025-03-31 compared with ₹171.42Cr in 2024-03-31.

Earnings per share (EPS) were ₹18.42 in 2025-03-31, compared with ₹18.65 in 2024-03-31.